| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
Total patient revenue, net | ||||||||
- | - | 4,355 | 3,756 | - | 3,272 | 2,525 | 604 | 234 |
Total revenue | ||||||||
3,321 | 4,243 | 4,355 | 3,756 | 2,769 | 3,272 | 2,525 | 634 | 267 |
Operating expenses: | ||||||||
Patient expenses | ||||||||
379 | 225 | 950 | 927 | 436 | 508 | 339 | 48 | 37 |
Salaries and benefits | ||||||||
2,926 | 2,987 | 2,878 | 2,593 | 2,064 | 2,020 | 1,674 | 588 | 446 |
Share-based compensation | ||||||||
81 | 103 | 112 | 171 | 3 | 3 | 3 | 3 | 3 |
Advertising and marketing | ||||||||
241 | 224 | 317 | 349 | 347 | 388 | 291 | 85 | 93 |
General and administrative | ||||||||
1,236 | 1,345 | 1,311 | 1,429 | 977 | 1,082 | 1,003 | 737 | 239 |
Depreciation and amortization | ||||||||
450 | 447 | 422 | 396 | 285 | 106 | 424 | 89 | 31 |
Total operating expenses | ||||||||
5,315 | 5,335 | 5,993 | 5,868 | 4,114 | 4,110 | 3,737 | 1,552 | 851 |
Operating loss | ||||||||
-1,993 | -1,091 | -1,637 | -2,111 | -1,344 | -837 | -1,212 | -917 | -583 |
Other expenses: | ||||||||
Interest income | ||||||||
- | - | 0 | 0 | - | 0 | 2 | 2 | 3 |
Other expenses | ||||||||
- | 0 | -0 | -0 | -15 | - | - | 18 | - |
Beneficial conversion interest expense | ||||||||
- | 0 | 0 | 0 | 639 | - | - | - | - |
Interest expense | ||||||||
76 | 68 | 74 | 85 | 30 | 51 | 45 | 32 | 23 |
Total other expenses | ||||||||
-76 | 78 | -74 | -84 | -685 | -51 | -43 | -12 | -20 |
Loss before equity in earnings (loss) of non-consolidated affiliate | ||||||||
- | - | -1,711 | -2,196 | - | -889 | -1,255 | -930 | -604 |
Equity in earnings (loss) of non-consolidated affiliate | ||||||||
- | - | - | - | - | 0 | -39 | 19 | -85 |
Net loss before income taxes | ||||||||
-2,070 | -1,012 | -1,711 | -2,196 | -2,030 | -889 | -1,255 | -949 | -689 |
Net loss | ||||||||
-2,070 | -1,012 | -1,711 | -2,196 | -2,030 | -889 | -1,255 | -949 | -689 |
Net loss attributable to the non-controlling interest | ||||||||
336 | 481 | -162 | -295 | 431 | 1,510 | -276 | -218 | -285 |
Net loss attributable to IMAC Holdings, Inc. | ||||||||
-1,733 | -1,448 | -1,548 | -1,900 | -1,599 | -937 | -979 | -731 | -404 |
Net loss per share attributable to common stockholders Basic and diluted | ||||||||
-0.18 | -0.15 | -0.19 | -0.23 | -0.27 | 0.00 | -0.22 | -0.16 | -0.09 |
Weighted average common shares outstanding Basic and diluted | ||||||||
9,611 | 8,622 | 8,366 | 8,106 | 5,919 | 4,533 | 4,533 | 4,533 | 4,533 |
Patient Revenues, Net [Member] | ||||||||
Total revenue | ||||||||
3,309 | - | - | - | 2,769 | - | - | - | - |
Patient Revenues [Member] | ||||||||
Total patient revenue, net | ||||||||
- | - | 8,712 | 8,887 | - | 8,115 | 6,072 | 1,414 | 532 |
Contractual Adjustments [Member] | ||||||||
Total patient revenue, net | ||||||||
- | - | -4,356 | -5,131 | - | -4,843 | -3,547 | -810 | -298 |
Management Fees [Member] | ||||||||
Total patient revenue, net | ||||||||
- | - | - | - | - | - | - | 30 | - |
Total revenue | ||||||||
12 | - | - | - | - | - | - | - | 33 |